• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外部可推广性的挑战:基于[镓]Ga-PSMA-11 PET的放射组学特征对原发性前列腺癌进行特征描述的双中心验证的见解,以组织病理学为参考。

The Challenge of External Generalisability: Insights from the Bicentric Validation of a [Ga]Ga-PSMA-11 PET Based Radiomics Signature for Primary Prostate Cancer Characterisation Using Histopathology as Reference.

作者信息

Ghezzo Samuele, Bharathi Praveen Gurunath, Duan Heying, Mapelli Paola, Sorgo Philipp, Davidzon Guido Alejandro, Bezzi Carolina, Chung Benjamin Inbeh, Samanes Gajate Ana Maria, Thong Alan Eih Chih, Russo Tommaso, Brembilla Giorgio, Loening Andreas Markus, Ghanouni Pejman, Grattagliano Anna, Briganti Alberto, De Cobelli Francesco, Sonn Geoffrey, Chiti Arturo, Iagaru Andrei, Moradi Farshad, Picchio Maria

机构信息

Faculty of Medicine and Surgery, Vita-Salute San Raffaele University, 20132 Milan, Italy.

Nuclear Medicine Department, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.

出版信息

Cancers (Basel). 2024 Dec 7;16(23):4103. doi: 10.3390/cancers16234103.

DOI:10.3390/cancers16234103
PMID:39682289
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11640655/
Abstract

: PSMA PET radiomics is a promising tool for primary prostate cancer (PCa) characterisation. However, small single-centre studies and lack of external validation hinder definitive conclusions on the potential of PSMA PET radiomics in the initial workup of PCa. We aimed to validate a radiomics signature in a larger internal cohort and in an external cohort from a separate centre. : One hundred and twenty-seven PCa patients were retrospectively enrolled across two independent hospitals. The first centre (IRCCS San Raffaele Scientific Institute, Centre 1) contributed 62 [Ga]Ga-PSMA-11 PET scans, 20 patients classified as low-grade (ISUP grade < 4), and 42 as high-grade (ISUP grade ≥ 4). The second centre (Stanford University Hospital, Centre 2) provided 65 [Ga]Ga-PSMA-11 PET scans, and 49 low-grade and 16 high-grade patients. A radiomics model previously generated in Centre 1 was tested on the two cohorts separately and afterward on the entire dataset. Then, we evaluated whether the radiomics features selected in the previous investigation could generalise to new data. Several machine learning (ML) models underwent training and testing using 100-fold Monte Carlo cross-validation, independently at both Centre 1 and Centre 2, with a 70-30% train-test split. Additionally, models were trained in one centre and tested in the other, and vice versa. Furthermore, data from both centres were combined for training and testing using Monte Carlo cross-validation. Finally, a new radiomics signature built on this bicentric dataset was proposed. Several performance metrics were computed. The previously generated radiomics signature resulted in an area under the receiver operating characteristic curve (AUC) of 80.4% when tested on Centre 1, while it generalised poorly to Centre 2, where it reached an AUC of 62.7%. When the whole cohort was considered, AUC was 72.5%. Similarly, new ML models trained on the previously selected features yielded, at best, an AUC of 80.9% for Centre 1 and performed at chance for Centre 2 (AUC of 49.3%). A new signature built on this bicentric dataset reached, at best, an average AUC of 91.4% in the test set. The satisfying performance of radiomics models when used in the original development settings, paired with the poor performance otherwise observed, emphasises the need to consider centre-specific factors and dataset characteristics when developing radiomics models. Combining radiomics datasets is a viable strategy to reduce such centre-specific biases, but external validation is still needed.

摘要

前列腺特异性膜抗原(PSMA)正电子发射断层扫描(PET)影像组学是一种很有前景的用于原发性前列腺癌(PCa)特征描述的工具。然而,小规模的单中心研究以及缺乏外部验证阻碍了就PSMA PET影像组学在PCa初始检查中的潜力得出明确结论。我们旨在在一个更大的内部队列以及来自另一个中心的外部队列中验证一个影像组学特征。

在两家独立医院对127例PCa患者进行了回顾性纳入。第一个中心(圣拉斐尔科学研究所IRCCS,中心1)提供了62例[镓]镓-PSMA-11 PET扫描,其中20例患者分类为低级别(国际泌尿病理学会(ISUP)分级<4),42例为高级别(ISUP分级≥4)。第二个中心(斯坦福大学医院,中心2)提供了65例[镓]镓-PSMA-11 PET扫描,以及49例低级别和16例高级别患者。之前在中心1生成的一个影像组学模型分别在两个队列上进行测试,然后在整个数据集上进行测试。然后,我们评估了在之前的研究中选择的影像组学特征是否能推广到新数据。使用100倍蒙特卡洛交叉验证对几个机器学习(ML)模型进行训练和测试,在中心1和中心2独立进行,训练集与测试集的划分比例为70 - 30%。此外,模型在一个中心进行训练并在另一个中心进行测试,反之亦然。此外,将两个中心的数据合并用于使用蒙特卡洛交叉验证进行训练和测试。最后,基于这个双中心数据集构建了一个新的影像组学特征。计算了几个性能指标。之前生成的影像组学特征在中心1进行测试时,受试者操作特征曲线(AUC)下面积为80.4%,而在中心2的泛化性较差,AUC为62.7%。当考虑整个队列时,AUC为72.5%。同样,基于之前选择的特征训练的新ML模型,在中心1的最佳AUC为80.9%,在中心2则表现不佳(AUC为49.3%)。基于这个双中心数据集构建的一个新特征在测试集中的最佳平均AUC达到了91.4%。影像组学模型在原始开发环境中使用时表现令人满意,而在其他情况下观察到的性能不佳,这强调了在开发影像组学模型时需要考虑中心特异性因素和数据集特征。合并影像组学数据集是减少此类中心特异性偏差的可行策略,但仍需要外部验证。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f13d/11640655/674028e30976/cancers-16-04103-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f13d/11640655/fad471479cb8/cancers-16-04103-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f13d/11640655/53ff98331172/cancers-16-04103-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f13d/11640655/7bfb0954412c/cancers-16-04103-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f13d/11640655/fe4d2307e350/cancers-16-04103-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f13d/11640655/674028e30976/cancers-16-04103-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f13d/11640655/fad471479cb8/cancers-16-04103-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f13d/11640655/53ff98331172/cancers-16-04103-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f13d/11640655/7bfb0954412c/cancers-16-04103-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f13d/11640655/fe4d2307e350/cancers-16-04103-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f13d/11640655/674028e30976/cancers-16-04103-g005.jpg

相似文献

1
The Challenge of External Generalisability: Insights from the Bicentric Validation of a [Ga]Ga-PSMA-11 PET Based Radiomics Signature for Primary Prostate Cancer Characterisation Using Histopathology as Reference.外部可推广性的挑战:基于[镓]Ga-PSMA-11 PET的放射组学特征对原发性前列腺癌进行特征描述的双中心验证的见解,以组织病理学为参考。
Cancers (Basel). 2024 Dec 7;16(23):4103. doi: 10.3390/cancers16234103.
2
Role of [Ga]Ga-PSMA-11 PET radiomics to predict post-surgical ISUP grade in primary prostate cancer.[Ga]Ga-PSMA-11 PET 放射组学预测原发性前列腺癌术后 ISUP 分级的作用。
Eur J Nucl Med Mol Imaging. 2023 Jul;50(8):2548-2560. doi: 10.1007/s00259-023-06187-3. Epub 2023 Mar 18.
3
Machine learning-based prediction of invisible intraprostatic prostate cancer lesions on  Ga-PSMA-11 PET/CT in patients with primary prostate cancer.基于机器学习的原发性前列腺癌患者 Ga-PSMA-11 PET/CT 上不可见的前列腺内癌病灶预测。
Eur J Nucl Med Mol Imaging. 2022 Apr;49(5):1523-1534. doi: 10.1007/s00259-021-05631-6. Epub 2021 Nov 30.
4
Optimization and validation of 18F-DCFPyL PET radiomics-based machine learning models in intermediate- to high-risk primary prostate cancer.基于 18F-DCFPyL PET 影像组学的机器学习模型在中高危初诊前列腺癌中的优化与验证。
PLoS One. 2023 Nov 9;18(11):e0293672. doi: 10.1371/journal.pone.0293672. eCollection 2023.
5
Supervised machine learning enables non-invasive lesion characterization in primary prostate cancer with [Ga]Ga-PSMA-11 PET/MRI.基于[Ga]Ga-PSMA-11 PET/MRI 的监督机器学习可实现原发性前列腺癌的无创性病变特征分析。
Eur J Nucl Med Mol Imaging. 2021 Jun;48(6):1795-1805. doi: 10.1007/s00259-020-05140-y. Epub 2020 Dec 19.
6
End-to-end [F]PSMA-1007 PET/CT radiomics-based pipeline for predicting ISUP grade group in prostate cancer.用于预测前列腺癌ISUP分级组的基于端到端[F]PSMA - 1007 PET/CT影像组学的流程
Abdom Radiol (NY). 2025 Apr;50(4):1641-1652. doi: 10.1007/s00261-024-04601-4. Epub 2024 Sep 30.
7
Development and validation of Ga-PSMA-11 PET/CT-based radiomics model to detect primary prostate cancer.基于Ga-PSMA-11 PET/CT的放射组学模型用于检测原发性前列腺癌的开发与验证
EJNMMI Res. 2022 Sep 30;12(1):63. doi: 10.1186/s13550-022-00936-5.
8
Radiomics Analysis on [Ga]Ga-PSMA-11 PET and MRI-ADC for the Prediction of Prostate Cancer ISUP Grades: Preliminary Results of the BIOPSTAGE Trial.基于[镓]镓-PSMA-11 PET和MRI-ADC对前列腺癌国际泌尿病理学会(ISUP)分级进行预测的影像组学分析:BIOPSTAGE试验的初步结果
Cancers (Basel). 2022 Apr 8;14(8):1888. doi: 10.3390/cancers14081888.
9
Machine learning-based analysis of Ga-PSMA-11 PET/CT images for estimation of prostate tumor grade.基于机器学习的 Ga-PSMA-11 PET/CT 图像分析用于估计前列腺肿瘤分级。
Phys Eng Sci Med. 2024 Jun;47(2):741-753. doi: 10.1007/s13246-024-01402-3. Epub 2024 Mar 25.
10
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.

引用本文的文献

1
Overcoming the blood-brain barrier (BBB) in pediatric CNS tumors: immunotherapy and nanomedicine-driven strategies.克服小儿中枢神经系统肿瘤中的血脑屏障:免疫疗法和纳米医学驱动策略
Med Oncol. 2025 Aug 19;42(10):431. doi: 10.1007/s12032-025-02984-y.
2
Previous maximal transurethral resection of bladder tumor lead to unfavorable perioperative outcomes following radical cystectomy.既往膀胱肿瘤经尿道最大程度切除术会导致根治性膀胱切除术后围手术期预后不良。
Int Urol Nephrol. 2025 Jun;57(6):1817-1826. doi: 10.1007/s11255-025-04368-7. Epub 2025 Jan 9.

本文引用的文献

1
Ga68-PSMA PET for lymph node staging in intermediate and high-risk prostate cancer patients undergoing robotic assisted radical prostatectomy.Ga68-PSMA PET 用于接受机器人辅助根治性前列腺切除术的中高危前列腺癌患者的淋巴结分期。
Minerva Urol Nephrol. 2024 Aug;76(4):467-473. doi: 10.23736/S2724-6051.24.05736-7.
2
Explanation and Elaboration with Examples for CLEAR (CLEAR-E3): an EuSoMII Radiomics Auditing Group Initiative.中文解释和举例说明(CLEAR-E3):EuSoMII 放射组学审核组的一项倡议。
Eur Radiol Exp. 2024 May 14;8(1):72. doi: 10.1186/s41747-024-00471-z.
3
What a Radiologist Needs to Know About Radiomics, Standardization, and Reproducibility.
放射科医生需要了解的关于放射组学、标准化和可重复性的知识。
Radiology. 2024 Feb;310(2):e232459. doi: 10.1148/radiol.232459.
4
The Image Biomarker Standardization Initiative: Standardized Convolutional Filters for Reproducible Radiomics and Enhanced Clinical Insights.影像生物标志物标准化倡议:用于可重复的放射组学和增强临床见解的标准化卷积滤波器。
Radiology. 2024 Feb;310(2):e231319. doi: 10.1148/radiol.231319.
5
METhodological RadiomICs Score (METRICS): a quality scoring tool for radiomics research endorsed by EuSoMII.方法学放射组学评分(METRICS):一种由欧洲医学影像信息学会(EuSoMII)认可的放射组学研究质量评分工具。
Insights Imaging. 2024 Jan 17;15(1):8. doi: 10.1186/s13244-023-01572-w.
6
Optimization and validation of 18F-DCFPyL PET radiomics-based machine learning models in intermediate- to high-risk primary prostate cancer.基于 18F-DCFPyL PET 影像组学的机器学习模型在中高危初诊前列腺癌中的优化与验证。
PLoS One. 2023 Nov 9;18(11):e0293672. doi: 10.1371/journal.pone.0293672. eCollection 2023.
7
Dual adversarial deconfounding autoencoder for joint batch-effects removal from multi-center and multi-scanner radiomics data.双对抗去混淆自动编码器用于从多中心和多扫描仪放射组学数据中联合去除批次效应。
Sci Rep. 2023 Nov 1;13(1):18857. doi: 10.1038/s41598-023-45983-7.
8
CheckList for EvaluAtion of Radiomics research (CLEAR): a step-by-step reporting guideline for authors and reviewers endorsed by ESR and EuSoMII.放射组学研究评估清单(CLEAR):由欧洲放射学会(ESR)和欧洲医学影像信息学会(EuSoMII)认可的作者和审稿人分步报告指南。
Insights Imaging. 2023 May 4;14(1):75. doi: 10.1186/s13244-023-01415-8.
9
Role of [Ga]Ga-PSMA-11 PET radiomics to predict post-surgical ISUP grade in primary prostate cancer.[Ga]Ga-PSMA-11 PET 放射组学预测原发性前列腺癌术后 ISUP 分级的作用。
Eur J Nucl Med Mol Imaging. 2023 Jul;50(8):2548-2560. doi: 10.1007/s00259-023-06187-3. Epub 2023 Mar 18.
10
Improved generalized ComBat methods for harmonization of radiomic features.改进的广义 ComBat 方法用于协调放射组学特征。
Sci Rep. 2022 Nov 8;12(1):19009. doi: 10.1038/s41598-022-23328-0.